Mucin-2 (MUC2)

"Pro-inflammatory mucoproteins in intestinal mucus" refers to a subset of glycosylated proteins, primarily the secreted gel-forming mucins such as Mucin-2 (MUC2), which constitute the major structural and functional components of the intestinal mucus barrier[1][2][3][6]. These mucins are secreted by goblet cells and organize the mucus into distinct layers, separating commensal microbes from the epithelium and modulating immune responses[2][5][6]. Alterations in mucin quality, quantity, or structural integrity are associated with gut inflammation (such as in inflammatory bowel disease), increased microbial translocation, and epithelial damage[1][2][5]. The term "mucoprotein" is outdated for scientific precision, and "pro-inflammatory" is context dependent: mucins themselves are not inherently pro-inflammatory but undergo changes during inflammation that can contribute to altered immunity and disease[1][6]. There is no canonical receptor or drug target called "pro-inflammatory mucoproteins in intestinal mucus"; the most specific and scientifically accurate molecule in this context is Mucin-2 (MUC2)[1][2][3][6]. MUC2 is the predominant gel-forming mucin in the intestine and is critical for maintaining a barrier that restricts microbial access to the epithelium[1][2][3][6]. Loss or alteration of MUC2 function or expression is causally implicated in intestinal inflammation, as seen in Muc2-deficient mice and patients with colitis[2][6]. While mucins can become altered in structure and function during gut inflammation, they are not themselves drug targets or receptors as typically defined in pharmacology — rather, they are large extracellular proteins required for barrier integrity[1][2][3][6].

Other names

intestinal mucinsgel-forming mucins